156 related articles for article (PubMed ID: 7990116)
1. Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives.
Gantchev TG; Ali H; van Lier JE
J Med Chem; 1994 Nov; 37(24):4164-76. PubMed ID: 7990116
[TBL] [Abstract][Full Text] [Related]
2. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
3. CoMFA and docking study of novel estrogen receptor subtype selective ligands.
Wolohan P; Reichert DE
J Comput Aided Mol Des; 2003; 17(5-6):313-28. PubMed ID: 14635724
[TBL] [Abstract][Full Text] [Related]
4. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
Wiese TE; Polin LA; Palomino E; Brooks SC
J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
Sadler BR; Cho SJ; Ishaq KS; Chae K; Korach KS
J Med Chem; 1998 Jun; 41(13):2261-7. PubMed ID: 9632359
[TBL] [Abstract][Full Text] [Related]
6. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
[TBL] [Abstract][Full Text] [Related]
8. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
9. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
[TBL] [Abstract][Full Text] [Related]
10. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes.
Tong W; Perkins R; Xing L; Welsh WJ; Sheehan DM
Endocrinology; 1997 Sep; 138(9):4022-5. PubMed ID: 9275094
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of A-ring fluorinated derivatives of (17 alpha,20E/Z)-[125I]iodovinylestradiols: effect on receptor binding and receptor-mediated target tissue uptake.
Ali H; Rousseau J; van Lier JE
J Med Chem; 1993 Oct; 36(21):3061-72. PubMed ID: 8230092
[TBL] [Abstract][Full Text] [Related]
12. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor.
Chitta A; Jatavath MB; Fatima S; Manga V
J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569
[TBL] [Abstract][Full Text] [Related]
13. CoMSIA and docking study of rhenium based estrogen receptor ligand analogs.
Wolohan P; Reichert DE
Steroids; 2007 Mar; 72(3):247-60. PubMed ID: 17280694
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional quantitative structure activity relationship (QSAR) of cytotoxic active 3,5-diaryl-4,5-dihydropyrazole analogs: a comparative molecular field analysis (CoMFA) revisited study.
Hamad Elgazwy AS; Soliman DS; Atta-Allah SR; Ibrahim DA
Chem Cent J; 2012 May; 6(1):50. PubMed ID: 22647291
[TBL] [Abstract][Full Text] [Related]
15. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
Opera TI; Waller CL; Marshall GR
Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, receptor binding, and tissue distribution of 7 alpha- and 11 beta-substituted (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diols.
Ali H; Rousseau J; Ghaffari MA; van Lier JE
J Med Chem; 1991 Feb; 34(2):854-60. PubMed ID: 1995909
[TBL] [Abstract][Full Text] [Related]
18. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
Brown ML; Zha CC; Van Dyke CC; Brown GB; Brouillette WJ
J Med Chem; 1999 May; 42(9):1537-45. PubMed ID: 10229624
[TBL] [Abstract][Full Text] [Related]
19. Binding research on flavones as ligands of β-amyloid aggregates by fluorescence and their 3D-QSAR, docking studies.
Yang Y; Zhu L; Chen X; Zhang H
J Mol Graph Model; 2010 Dec; 29(4):538-45. PubMed ID: 21094069
[TBL] [Abstract][Full Text] [Related]
20. CoMFA QSAR models of camptothecin analogues based on the distinctive SAR features of combined ABC, CD and E ring substitutions.
Virupaksha B; Alpana G
Comput Biol Med; 2012 Sep; 42(9):890-7. PubMed ID: 22840194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
